Excitotoxicity
In excitotoxicity,
Excitotoxicity may be involved in
History
The harmful effects of glutamate on the
In 2002, Hilmar Bading and co-workers found that excitotoxicity is caused by the activation of NMDA receptors located outside synaptic contacts.[12] The molecular basis for toxic extrasynaptic NMDA receptor signaling was uncovered in 2020 when Hilmar Bading and co-workers described a death signaling complex that consists of extrasynaptic NMDA receptor and TRPM4.[13] Disruption of this complex using NMDAR/TRPM4 interface inhibitors (also known as ‚interface inhibitors‘) renders extrasynaptic NMDA receptor non-toxic.[citation needed]
Pathophysiology
Excitotoxicity can occur from substances produced within the body (
This pathologic phenomenon can also occur after
Increased extracellular glutamate levels leads to the activation of Ca2+ permeable NMDA receptors on myelin sheaths and
Inadequate ATP production resulting from brain trauma can eliminate electrochemical gradients of certain ions. Glutamate transporters require the maintenance of these ion gradients to remove glutamate from the extracellular space. The loss of ion gradients results in not only the halting of glutamate uptake, but also in the reversal of the transporters. The Na+-glutamate transporters on neurons and astrocytes can reverse their glutamate transport and start secreting glutamate at a concentration capable of inducing excitotoxicity.[23] This results in a buildup of glutamate and further damaging activation of glutamate receptors.[24]
On the
Exogenous excitotoxins
Exogenous excitotoxins refer to neurotoxins that also act at postsynaptic cells but are not normally found in the body. These toxins may enter the body of an organism from the environment through wounds, food intake, aerial dispersion etc.[27] Common excitotoxins include glutamate analogs that mimic the action of glutamate at glutamate receptors, including AMPA and NMDA receptors.[28]
BMAA
The L-alanine derivative β-methylamino-L-alanine (
See also
- Glutamatergic system
- Glutamic acid (flavor)
- NMDA receptor antagonist
- Dihydropyridine
References
- ^ PMID 19545440.
- PMID 2568579.
- PMID 20516644.
- PMID 1355259.
- ^ Kim AH, Kerchner GA, and Choi DW. Blocking Excitotoxicity or Glutamatergic Storm. Chapter 1 in CNS Neuroprotection. Marcoux FW and Choi DW, editors. Springer, New York. 2002. Pages 3-36
- S2CID 20197292.
- PMID 16314180.
- S2CID 27515308.
- PMID 16402093.
- PMID 13443577.
- S2CID 46248201.
- S2CID 659716.
- S2CID 222210921.
- ^ Temple MD, O'Leary DM, and Faden AI. The role of glutamate receptors in the pathophysiology of traumatic CNS injury. Chapter 4 in Head Trauma: Basic, Preclinical, and Clinical Directions. Miller LP and Hayes RL, editors. Co-edited by Newcomb JK. John Wiley and Sons, Inc. New York. 2001. Pages 87-113.
- PMID 1359647.
- S2CID 4430535.
- PMID 7576644.
- PMID 19154757.
- PMID 20447471.
- ^ PMID 20946934.
- PMID 15721979.
- PMID 29928190.
- S2CID 25693141.
- ISBN 9780080472072.
- ^ S2CID 659716.
- PMID 20842175.
- S2CID 37986519.
- S2CID 22391321.
- ^ PMID 22885173.
- S2CID 24476846.
- ISBN 9789289315418.
- PMID 24086518.
- PMID 22382274.
- PMID 26791617.
Further reading
- Kandel ER, Schwartz JH, Jessel TM (2000). Principles of Neural Science (4th ed.). McGraw Hill. p. 928.
- ISBN 0-929173-25-2.[page needed]
- Lau A, Tymianski M (July 2010). "Glutamate receptors, neurotoxicity and neurodegeneration". Pflügers Archiv. 460 (2): 525–542. S2CID 12421120. Invited Review